These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2160123)

  • 21. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
    Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
    J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission.
    Nerurkar VR; Chua PK; Hoffmann PR; Dashwood WM; Shikuma CM; Yanagihara R
    J Med Virol; 1998 Oct; 56(2):123-7. PubMed ID: 9746067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
    Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
    Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users.
    Ferreira RC; Rodrigues FP; Teles SA; Lopes CL; Motta-Castro AR; Novais AC; Souto FJ; Martins RM
    J Med Virol; 2009 Apr; 81(4):602-9. PubMed ID: 19235862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts.
    Baozhang T; Kaining Z; Jinxing K; Ruchang X; Ming L; Caixia Z; Li T
    Epidemiol Infect; 1997 Dec; 119(3):343-7. PubMed ID: 9440438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence of chronic viral hepatitis in drug abusers].
    Osztrogonácz H; Gerevich J; Horváth G; Tolvaj G; Dávid K
    Orv Hetil; 2000 Apr; 141(14):715-8. PubMed ID: 10803013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence of serological markers of hepatitis B and C viruses and HIV in a population of drug abusers hospitalized from 1990 to 1992].
    Schmitt C; Bertel J; Jacob C
    Ann Med Interne (Paris); 1994; 145(1):7-12. PubMed ID: 8192286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users.
    Lin CL; Liu CJ; Chen PJ; Lai MY; Chen DS; Kao JH
    J Med Virol; 2007 Nov; 79(11):1674-8. PubMed ID: 17854041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HBV, HCV and HIV infections among drug addicts-residents of rehabilitation and social adjustment centers in the Gdańsk district].
    Smiatacz T; Własiuk M; Paszkiewicz J; Zielińska W
    Przegl Epidemiol; 1991; 45(4):351-5. PubMed ID: 1841415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of markers of hepatitis viruses A, B, C and of HIV in healthy individuals and patients of a Cambodian province.
    Thüring EG; Joller-Jemelka HI; Sareth H; Sokhan U; Reth C; Grob P
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):239-49. PubMed ID: 7505485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W; Stanley J; Langton D; Kelly Y; Bury G
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiologic studies on HCV and HBV infections among intravenous drug users in the area with high HIV infection].
    Cheng H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):275-8. PubMed ID: 8137408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serological markers of selected viral infections transmitted by parenteral route in drug addicts].
    Halota W; Opoka J; Trzciński J; Dorau M; Topczewska E; Giziński W; Bulik F
    Przegl Epidemiol; 1991; 45(4):347-9. PubMed ID: 1668703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users.
    Anastassopoulou CG; Paraskevis D; Sypsa V; Psichogiou M; Katsoulidou A; Tassopoulos N; Skoutelis A; Malliori M; Hatzakis A
    J Med Virol; 1998 Nov; 56(3):246-52. PubMed ID: 9783693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of occult hepatitis B in Baltimore injection drug users.
    Torbenson M; Kannangai R; Astemborski J; Strathdee SA; Vlahov D; Thomas DL
    Hepatology; 2004 Jan; 39(1):51-7. PubMed ID: 14752822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.